IPGGF yields 1654.26% · PFE yields 6.20%● Live data
📍 IPGGF pulled ahead of the other in Year 1
Combined, IPGGF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IPGGF + PFE for your $10,000?
Imperium Technology Group Limited, an investment holding company, manufactures and sells household furnishing products and accessories. The company operates through six segments: Game Publishing, Cloud Computing and Data Storage, Esports, Household Products, Property Investment, and Money Lending. It produces stainless steel home furnishing products for kitchens and bathrooms; and offers diversified financial products, including personal loans, home mortgages, equity financing and mortgage, and corporate finance. The company is also involved in cryptocurrency mining and rental of machines to customers to engage in cryptocurrency mining; and participating in esports competitions, streaming and marketing events, and merchandise sales. In addition, it invests in properties; and designs and develops mobile and computer games in Hong Kong, the People's Republic of China, East and South Asia, and internationally. The company was formerly known as Imperium Group Global Holdings Limited and changed its name to Imperium Technology Group Limited in July 2021. Imperium Technology Group Limited was founded in 1999 and is based in Kwun Tong, Hong Kong. Imperium Technology Group Limited is a subsidiary of Diamond State Holdings Limited.
Full IPGGF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.